Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marco Sorio
Observed names:
M Sorio,
M. Sorio,
Marco Sorio (243802),
Sorio M
Institution:
Azienda Ospedaliera Universitaria Integrata Verona
Observed institutions:
University of Verona,
University of Milan,
Azienda Ospedaliera Universitaria Integrata Verona,
IRCCS Ospedale San Raffaele,
Fondazione IRCCS Istituto Nazionale dei Tumori,
Azienda Ospedaliera Carlo Poma,
University of Turin
show all 7
ORCID:
0000-0001-9155-6618
Observed ORCID:
0000-0001-9155-6618
OpenAlex ID:
A5042394865
Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma
2010
·
Corrado Tarella
, Roberto Passera
, et al.
·
Journal of Clinical Oncology
·
175
PDF
The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study
2015
·
Cinzia Scambi
, Sara Ugolini
, et al.
·
PLoS ONE
·
32
PDF
Brentuximab vedotin: axonal microtubule’s Apollyon
2015
·
S Mariotto
, S Ferrari
, et al.
·
Blood Cancer Journal
·
28
PDF
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy
2019
·
Sara Mariotto
, Cristina Tecchio
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
26
Comparative Proteomic Analysis of Serum from Patients with Systemic Sclerosis and Sclerodermatous GVHD. Evidence of Defective Function of Factor H
2010
·
Cinzia Scambi
, Valentina La Verde
, et al.
·
PLoS ONE
·
26
PDF
Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial
2006
·
M Ladetto
, S Vallet
, et al.
·
Leukemia
·
21
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case–control study
2019
·
Alberto Bedogni
, Giordana Bettini
, et al.
·
Journal of Cranio-Maxillofacial Surgery
·
20
Clinical, Serologic and Instrumental Data of Ten Patients Affected by Sclerodermatous Chronic Graft versus Host Disease: Similarities and Differences in Respect to Systemic Sclerosis
2010
·
G. Barausse
, P. Caramaschi
, et al.
·
International Journal of Immunopathology and Pharmacology
·
16
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience
2021
·
Fulvio Massaro
, Vincenzo Pavone
, et al.
·
Hematological Oncology
·
15
PDF
Epirubicin, Cisplatin and Continuous Infusion 5-Fluorouracil (ECF) in Locally Advanced or Metastatic Gastric Cancer: A Single Institution Experience
2001
·
Enrico Aitini
, Carla Rabbi
, et al.
·
Tumori Journal
·
8
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies
2024
·
Simonetta Viviani
, Anna Vanazzi
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
3
Treatment of very high-risk classical Hodgkin Lymphoma: cases' selection from real life and critical review of the literature.
2020
·
Chiara Rusconi
, Sabino Ciavarella
, et al.
·
Acta bio-medica dell'Ateneo parmense/Acta biomedica
·
3
PDF
Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation
2020
·
Umberto Restelli
, Davide Croce
, et al.
·
Journal of Blood Medicine
·
3
PDF
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia
2024
·
E Tamellini
, M Sorio
, et al.
·
BLOOD CELL THERAPY / The official journal of APBMT
·
2
PDF
The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series
2012
·
Cristina Tecchio
, Federico Mosna
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
2
Male Gender, Quality of Grafted Cells, Advanced Age, Rituximab and Radiotherapy Are the Main Factors That Variously Influence the Occurrence of Secondary Malignancies Following High-Dose Therapy and Autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) Survey in 1,347 Lymphoma Patients.
2009
·
Corrado Tarella
, Roberto Passera
, et al.
·
Blood
·
1
Pet-2 Positive during Frontline Therapy: An Early Unfavorable Predictor for Subsequent Salvage High-Dose Chemotherapy (HD-CT) and Autologous Stem Cell Transplant in Relapsed or Refractory Classical Hodgkin Lymphoma
2023
·
Simonetta Viviani
, Anna Vanazzi
, et al.
·
Blood
PDF
Author response for "Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: a Fondazione Italiana Linfomi real‐life experience"
2021
·
Fulvio Massaro
, Vincenzo Pavone
, et al.
·
Publons reviews and discussion
Brentuximab Vedotin Consolidation After Autologous Stem Cells Transplantation for Hodgkin Lymphoma: a Real‐life Experience by Fondazione Italiana Linfomi (fil)
2021
·
F. Massaro
, V. Pavone
, et al.
·
Hematological Oncology
Factors influencing the occurrence of secondary malignancies in high-risk lymphoma patients following high-dose therapy and autograft
2010
·
Tarella C
, Passera R
, et al.
·
Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele
Analisi proteomica del siero di pazienti reumatici affetti da sclerodermia e di pazienti ematologici sottoposti a trapianto con midollo che hanno sviluppato un rigetto scleroderma-like.
2008
·
Cinzia Scambi
, Giovanni Barausse
, et al.
High-Dose Sequential Chemotherapy (HDS) Followed by Autologous Stem Cell Transplantation (ASCT) in Relapsing/Refractory Hodgkin Lymphoma (HL): Long-Term Results.
2007
·
Andrea Gallamini
, Claudia Castellino
, et al.
·
Blood
Impact of complete remission achievement on the survival of lymphoma patients undergoing high-dose sequential chemotherapy and autograft (HDS programme): a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) retrospective study on 1,266 patients
2007
·
Tarella C
, Zanni M
, et al.
·
Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele
Favorable Influence of Rituximab with High Dose Sequential Chemotherapy (R-HDS) Programs and Autologous Stem Cell Transplantation (ASCT) in Salvage Treatment for Patients with Refractory or Relapsed B-Cell Non-Hodgkin’s Lymphoma.
2006
·
Milena Pintimalli
, Michael Mian
, et al.
·
Blood
Prolonged Survival of Lymphoma Patients Achieving Complete Remission Following High-Dose Sequential Chemotherapy and Autograft (HDS Program): A GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) Retrospective Study on 1,266 Patients.
2006
·
Corrado Tarella
, Manuela Zanni
, et al.
·
Blood
Show more works
View as search
Works count:
37
Citation count:
381
H-index:
9
I10-index:
9
Year
Topic
Type